86 related articles for article (PubMed ID: 28189683)
1. Anti-tumor effect of evodiamine by inducing Akt-mediated apoptosis in hepatocellular carcinoma.
Yang F; Shi L; Liang T; Ji L; Zhang G; Shen Y; Zhu F; Xu L
Biochem Biophys Res Commun; 2017 Mar; 485(1):54-61. PubMed ID: 28189683
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and bioactivity evaluation of novel N-phenyl-substituted evodiamine derivatives as potent anti-tumor agents.
Hao X; Deng J; Zhang H; Liang Z; Lei F; Wang Y; Yang X; Wang Z
Bioorg Med Chem; 2022 Feb; 55():116595. PubMed ID: 34990980
[TBL] [Abstract][Full Text] [Related]
3. Enhancing apoptosis-mediated anticancer activity of evodiamine through protein-based nanoparticles in breast cancer cells.
Solanki R; Rajput PK; Jodha B; Yadav UCS; Patel S
Sci Rep; 2024 Jan; 14(1):2595. PubMed ID: 38297059
[TBL] [Abstract][Full Text] [Related]
4. Evodiamine and its nano-based approaches for enhanced cancer therapy: recent advances and challenges.
Solanki R; Patel S
J Sci Food Agric; 2024 May; ():. PubMed ID: 38821861
[TBL] [Abstract][Full Text] [Related]
5. Author Correction: Enhancing apoptosis-mediated anticancer activity of evodiamine through protein-based nanoparticles in breast cancer cells.
Solanki R; Rajput PK; Jodha B; Yadav UCS; Patel S
Sci Rep; 2024 Mar; 14(1):6213. PubMed ID: 38486084
[No Abstract] [Full Text] [Related]
6. Evodiamine Exerts an Anti-Hepatocellular Carcinoma Activity through a WWOX-Dependent Pathway.
Hu CY; Wu HT; Su YC; Lin CH; Chang CJ; Wu CL
Molecules; 2017 Jul; 22(7):. PubMed ID: 28708106
[TBL] [Abstract][Full Text] [Related]
7. Evodiamine Induces Apoptosis, G2/M Cell Cycle Arrest, and Inhibition of Cell Migration and Invasion in Human Osteosarcoma Cells via Raf/MEK/ERK Signalling Pathway.
Zhou Y; Hu J
Med Sci Monit; 2018 Aug; 24():5874-5880. PubMed ID: 30135419
[TBL] [Abstract][Full Text] [Related]
8. Evodiamine in combination with histone deacetylase inhibitors has synergistic cytotoxicity in thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Lee SJ
Endocrine; 2019 Jul; 65(1):110-120. PubMed ID: 31102069
[TBL] [Abstract][Full Text] [Related]
9. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells.
Hong Z; Wang Z; Zhou B; Wang J; Tong H; Liao Y; Zheng P; Jamshed MB; Zhang Q; Chen H
Int J Oncol; 2020 Mar; 56(3):783-793. PubMed ID: 31922213
[TBL] [Abstract][Full Text] [Related]
10. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.
Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL
Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900
[TBL] [Abstract][Full Text] [Related]
11. Evodiamine and rutaecarpine from Tetradium ruticarpum in the treatment of liver diseases.
Li X; Ge J; Zheng Q; Zhang J; Sun R; Liu R
Phytomedicine; 2020 Mar; 68():153180. PubMed ID: 32092638
[TBL] [Abstract][Full Text] [Related]
12. Evodiamine inhibits migration and invasion by Sirt1-mediated post-translational modulations in colorectal cancer.
Zhou P; Li XP; Jiang R; Chen Y; Lv XT; Guo XX; Tian K; Yuan DZ; Lv YW; Ran JH; Li J; Chen DL
Anticancer Drugs; 2019 Jul; 30(6):611-617. PubMed ID: 30789361
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives.
Hu X; Li D; Chu C; Li X; Wang X; Jia Y; Hua H; Xu F
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380774
[TBL] [Abstract][Full Text] [Related]
14. Evodiamine Induces Cell Growth Arrest, Apoptosis and Suppresses Tumorigenesis in Human Urothelial Cell Carcinoma Cells.
Shi CS; Li JM; Chin CC; Kuo YH; Lee YR; Huang YC
Anticancer Res; 2017 Mar; 37(3):1149-1159. PubMed ID: 28314276
[TBL] [Abstract][Full Text] [Related]
15. Evodiamine Eliminates Colon Cancer Stem Cells via Suppressing Notch and Wnt Signaling.
Kim H; Yu Y; Choi S; Lee H; Yu J; Lee JH; Kim WY
Molecules; 2019 Dec; 24(24):. PubMed ID: 31835579
[TBL] [Abstract][Full Text] [Related]
16. Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer.
Li C; Cai G; Song D; Gao R; Teng P; Zhou L; Ji Q; Sui H; Cai J; Li Q; Wang Y
Biomater Sci; 2019 Aug; 7(9):3627-3639. PubMed ID: 31328737
[TBL] [Abstract][Full Text] [Related]
17. Evodiamine, a Novel NOTCH3 Methylation Stimulator, Significantly Suppresses Lung Carcinogenesis
Su T; Yang X; Deng JH; Huang QJ; Huang SC; Zhang YM; Zheng HM; Wang Y; Lu LL; Liu ZQ
Front Pharmacol; 2018; 9():434. PubMed ID: 29765324
[TBL] [Abstract][Full Text] [Related]
18. Evodiamine Mitigates Cellular Growth and Promotes Apoptosis by Targeting the c-Met Pathway in Prostate Cancer Cells.
Hwang ST; Um JY; Chinnathambi A; Alharbi SA; Narula AS; Namjoshi OA; Blough BE; Ahn KS
Molecules; 2020 Mar; 25(6):. PubMed ID: 32183146
[TBL] [Abstract][Full Text] [Related]
19. Evodiamine ameliorates paclitaxel-induced neuropathic pain by inhibiting inflammation and maintaining mitochondrial anti-oxidant functions.
Wu P; Chen Y
Hum Cell; 2019 Jul; 32(3):251-259. PubMed ID: 30701373
[TBL] [Abstract][Full Text] [Related]
20. Evodiamine suppresses non-small cell lung cancer by elevating CD8
Jiang ZB; Huang JM; Xie YJ; Zhang YZ; Chang C; Lai HL; Wang W; Yao XJ; Fan XX; Wu QB; Xie C; Wang MF; Leung EL
J Exp Clin Cancer Res; 2020 Nov; 39(1):249. PubMed ID: 33208183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]